The University of Texas Health Science Center at Houston (UTHealth Houston)
Postdoc (Medical genetics and biology/biochemistry of novel tumor suppressors EXT1 and EXT2)
1997 - 2000
Oregon State University
Ph.D. (Biochemistry and Biophysics)
Harvard Medical School
Instructor in Medicine and Research Fellow (Advanced research focuses on HIV, innate immunity, viral microRNAs, RNA interference and signaling.)
UCLA
Mark Bernard Skills
Drug Discovery
Enzyme Kinetics
Assay Development
Biochemistry
In Vitro
Protein Chemistry
Oncology
qPCR
DNA
Pharmaceutical Industry
Mark Bernard Summary
Mark Bernard, based in San Diego, CA, US, is currently a President at Capienda Biotech. Mark Bernard brings experience from previous roles at Omniome Inc., Harvard Medical School and Pfizer. Mark Bernard holds a 1997 - 2000 Postdoc in Medical genetics and biology/biochemistry of novel tumor suppressors EXT1 and EXT2 @ The University of Texas Health Science Center at Houston (UTHealth Houston). With a robust skill set that includes Drug Discovery, Enzyme Kinetics, Assay Development, Biochemistry, In Vitro and more. Mark Bernard has 4 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.